Biotech Stocks Surge December 21: Rising Flu Cases Drive Market Rally

Biotech stocks are experiencing a notable surge in Canada as flu cases, particularly from the H3N2 strain, rise sharply. This uptick in influenza-related health concerns is driving heightened demand for vaccines and treatments, reflecting positively on companies within this sector. With increased flu activity reported nationwide, investors are keenly observing the biotech industry for potential growth opportunities.